The metabolism drugs market is witnessing significant expansion as healthcare systems worldwide focus on addressing the growing burden of metabolic disorders. These medications play a crucial role in managing conditions associated with abnormal metabolic processes, including inherited metabolic diseases, enzyme deficiencies, and various chronic disorders that affect the body's ability to...

NEWARK, DE | The Weight Loss and Obesity Management Market stood at USD 16.3 billion in 2025 and is forecast to reach USD 54.4 billion by 2035, advancing at a robust CAGR of 12.8%. This trajectory underscores the urgent global response to obesity as a major public health challenge, alongside growing preference for integrated approaches that combine pharmaceuticals, minimally...